Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C4 Deficiency”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT03029728
What this trial is testing

Biomarker for Hereditary AngioEdema Disease

Who this might be right for
C1 Esterase Inhibitor DeficiencyAngio EdemaC4 Deficiency+5 more
CENTOGENE GmbH Rostock 42
Testing effectiveness (Phase 2)Looking for participantsNCT07046806
What this trial is testing

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema (HAE)AngioedemaBradykinin-mediated Angioedema+1 more
Institute for Asthma and Allergy 10
Early research (Phase 1)Study completedNCT00000886
What this trial is testing

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00001060
What this trial is testing

A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableUnknownNCT05122481
What this trial is testing

Vitamin C 4 Care Homes

Who this might be right for
HypovitaminosisVitamin C Abnormal
University of Aberdeen 20
Early research (Phase 1)Study completedNCT00005779
What this trial is testing

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12